PRESS RELEASE: Attend Technology for Precision Health Summit and Learn the Next Tech Wave to Impact Personalized Health
Contact: Tarek Cotran
Conference Director, Health 2.0
WASHINGTON DC, USA -- HIT/HIPAA UPDATE NEWS SERVICE -- NOVEMBER 15, 2017: The Technology For Precision Health Summit is just around the corner, and it's the place to discover new digital platforms that will improve the patient experience, and access a deeper insight into the data behind key decisions for treatment and for maintaining health.
Join more than 300 healthcare providers and payers, advocates, developers, investors, entrepreneurs, policymakers, and advocates for the 1-day action-packed summit which includes:
- Keynote presentation on quality of patient experience; and initiatives to improve care providers to securely review, analyze and share medical information across the healthcare system by Claudia Williams, CEO of Manifest MedEx; and a presentation by Carlos Bustamante, Professor of Biomedical Data Science, of Genetics at Stanford Medicine on Stanford Medicine's precision health initiative, and an insight into its Precision Health and Integrated Diagnostics Center.
- Presentations and demos from Syapse and Cota focusing on genomics and other omics technologies that are rapidly making their way to clinicians and into Electronic Health Care Records (EHRs) during the Precision Medicine - Decision Support for Clinicians session.
- New Diagnostic and Screening Tools session featuring live demos from Helix, DotLab, Ivary, and ColorGenomics.
- An in-depth look at funding sources for precision medicine and health as well as insight on how value based medicine and population health incentives and policy are shaping investment with Illumina Accelerator, GE Ventures, Cricket Health, and the California Governor's Office of Planning and Research during the Business Models and Investing in Precision Health session.
What are you waiting for? Register for the Technology for Precision Health Summit to see healthcare technology demos from some of the most innovative personalized medicine companies, and hear penetrating discussions on precision medicine delivery, innovation in clinical trials, and advances in oncology.